THINK Surgical Secures up to $65 Million of Growth Capital

THINK Surgical Secures up to $65 Million of Growth Capital

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

THINK Surgical, Inc., a leading innovator of orthopedic surgical robots, announced it has entered into a debt facility with Symbiotic Capital to provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital. The proceeds will be used by THINK to continue to advance its dual channel commercial strategy for its TMINI® Miniature Robotic System.

WilmerHale advised THINK in the transaction.

The WilmerHale team was led by Glenn Pollner, Brandt Tierney, and Avery Reaves, and included Michael Katz, Jordana Tonkiss, Jamie Wolf, and Ariana Raitano, with additional assistance from Meghan Walsh, Amanda Albert, Jeff Johnson, Andrew Walsh, Katelyn Schwartz, and Louise Luongo.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel